Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
News
All
Editors' Picks
Stocks
Indices
Market Movers
Commodities
Cryptocurrencies
Forex
Earnings
Transcripts
Technical Analysis
Economic Indicator
Other
Hamilton Beach Q2 2026 Earnings: Tariff Refunds Drive the Margin Surge
Hamilton Beach Brands Holding Company (NYSE: HBB) reported Q2 2026 revenue of $142.6 million, up 11.6%, and diluted EPS of $2.49 versus $0.33 a year earlier. Reported gross margin reached 54.3%, but one-time IEEPA tariff refunds and related inventory benefits were the main driver; excluding them, margin would have been 26.1%. The company reiterated its mid-single-digit 2026 revenue growth outlook, improved its gross-margin and operating-profit guidance, and maintained a $35 million to $45 million outlook for operating cash flow less investing activities.
Hamilton Beach Brands Holding Co
TradingKey
Wed, Aug 5
Raytech fiscal 2026 earnings: New services lift revenue and margins
Raytech (Nasdaq: RAY) reported fiscal 2026 revenue of HK$142.6 million, up 81.1%, and net income of HK$16.7 million, up 101.9%. New design, advisory and marketing services contributed HK$44.2 million, or 31.0% of revenue, helping lift operating margin to 12.6% from 9.7%. Diluted EPS nevertheless declined to HK$7.19 from HK$7.60 as the weighted share count expanded. Operating cash flow was negative HK$14.5 million because of a year-end receivables buildup, although the company said those receivables were subsequently collected in full.
Raytech Holding Ltd
TradingKey
Wed, Aug 5
Brookfield Asset Management Q2 2026 Earnings: Fee-Related Earnings Rise 20%
Brookfield Asset Management (BAM) reported Q2 2026 revenue of US$1.75 billion, up about 61% from US$1.09 billion, while diluted GAAP EPS increased to US$0.56 from US$0.38. Fee-related earnings rose 20% to US$808 million and distributable earnings advanced 15% to US$707 million, supported by record quarterly fundraising and 19% growth in fee-bearing capital. A favorable carried-interest swing amplified GAAP growth, while credit supplied most of the quarter’s US$77 billion of fundraising.
TradingKey
Wed, Aug 5
Global Indemnity Q2 2026 earnings: Premium growth meets higher expense pressure
Global Indemnity Group’s Q2 2026 total revenue increased about 5% to $116.1 million, and diluted EPS rose to $0.76 from $0.71. Net income reached $11.1 million, while Belmont Core gross written premiums grew 6.8% to $117.3 million, led by Assumed Reinsurance. Underwriting results were mixed: the loss ratio improved to 53.8%, but a higher expense ratio pushed the combined ratio to 95.0%. Non-GAAP operating income fell to $8.7 million, and book value per share declined to $48.28.
Global Indemnity Group LLC
TradingKey
Wed, Aug 5
UroGen Q2 2026 Earnings: ZUSDURI Launch Nearly Triples Revenue
UroGen Pharma (URGN) reported Q2 2026 revenue of $72.5 million, up approximately 199% year over year, as ZUSDURI contributed $50.4 million during its commercial launch. Gross margin rose to about 90.9%, and the company reached a small $0.1 million operating profit, but financing, interest and tax expenses left a $14.4 million net loss, or $0.28 per share. UroGen also raised 2026 operating-expense guidance to $260 million-$270 million while maintaining JELMYTO revenue guidance of $97 million-$101 million.
Urogen Pharma Ltd
TradingKey
Wed, Aug 5
Atlanta Braves Holdings Q2 2026 earnings: Baseball cost growth drives an operating loss
Atlanta Braves Holdings’ Q2 2026 revenue fell 2% to $305.1 million, while diluted EPS swung to a $0.19 loss from a $0.46 profit. Operating results weakened more sharply: the company posted an $18.5 million operating loss and Adjusted OIBDA fell 82% to $11.8 million. Six fewer home games reduced baseball event revenue, while media revenue also declined. Higher player salaries, BravesVision production and marketing costs, special-event expenses, and MLB shared costs pressured profitability, partly offset by 14% growth in Mixed-Use Development revenue. Debt also rose during the quarter to support seasonal working capital.
Atlanta Braves Holdings Inc
TradingKey
Wed, Aug 5
SmartRent Q2 2026 earnings: Gross margin expansion turns adjusted EBITDA positive
SmartRent’s Q2 2026 revenue rose 4% to $39.8 million, while Core Revenue increased 14% to $38.4 million. Gross margin expanded 760 basis points to 40.7%, and adjusted EBITDA improved to positive $0.7 million from a $7.3 million loss. The GAAP net loss narrowed 48% to $5.6 million, or $0.03 per diluted share. SaaS growth and professional-services installations offset lower hardware revenue, while booked units nearly doubled. SmartRent ended June with $92.7 million in cash, no debt, and an undrawn $75 million credit facility.
SmartRent Inc
TradingKey
Wed, Aug 5
Rand Capital Q2 2026 Earnings: Non-Accruals Reduce Investment Income
Rand Capital’s Q2 fiscal 2026 total investment income fell 13% to $1.4 million as non-accrual investments reduced interest income and portfolio yield. Adjusted net investment income declined to $0.24 per share from $0.33, while a $959,000 realized gain from the Applied Image exit supported the overall increase in net assets from operations. The portfolio reached $56.5 million in fair value, and NAV was $17.33 per share at June 30, 2026, as new deployment lowered cash and increased credit-line borrowings.
Rand Capital Corp
TradingKey
Wed, Aug 5
Trinity Capital Q2 2026 earnings: Investment income rises while per-share NII slips
Trinity Capital (NYSE: TRIN) reported Q2 2026 total investment income of $87.2 million, up 25.5% year over year, and record net investment income of $46.0 million. Diluted NII per share slipped to $0.51 from $0.53 as the weighted average share count increased, while interest expense rose to $24.8 million. The portfolio reached about $2.7 billion in fair value, NAV increased sequentially to $13.47 per share, and available liquidity ended the quarter at $430.1 million with net leverage at 118%.
TradingKey
Wed, Aug 5
Avnet Fiscal Q4 2026 Earnings: Record Sales Lift Operating Margins
Avnet’s fiscal Q4 2026 revenue reached a record $8.30 billion, up 47.7% year over year, while diluted EPS increased to $1.49 from $0.07. Adjusted operating margin expanded 129 basis points to 3.8%, with Electronic Components revenue up 49.0% and Farnell revenue up 29.4%. Fiscal 2026 operating cash flow was negative $280.9 million as receivables and inventory absorbed cash. Avnet guided fiscal Q1 2027 sales to $9.00-$9.30 billion and adjusted diluted EPS to $2.80-$2.90, implying approximately 10% sequential sales growth at the revenue midpoint.
Avnet Inc
TradingKey
Wed, Aug 5
OSS Q2 2026 Earnings: Revenue Rose 62% as a Legal Settlement Widened the Loss
One Stop Systems (OSS) reported Q2 2026 revenue from continuing operations of $9.3 million, up 62.3% year over year, while diluted EPS fell to a loss of $0.29 from $0.11. A $6.25 million legacy legal settlement drove the wider GAAP loss, but non-GAAP EPS improved to a loss of $0.01 and adjusted EBITDA loss narrowed to $0.3 million. Record bookings of $15.1 million supported raised full-year revenue growth guidance of 25%-30%, while gross margin declined to 39.1% because of product mix and early-stage program work.
One Stop Systems Inc
TradingKey
Wed, Aug 5
Holley Q2 2026 Earnings: Core Sales Rise as a Divestiture Charge Drives a GAAP Loss
Holley’s Q2 2026 net sales rose 3.2% to $172.0 million, while core business sales increased 4.9%. GAAP diluted EPS fell to $(0.02) from $0.09 as a $28.3 million loss on the sale of non-core assets pushed the company to a $2.4 million net loss. Adjusted EBITDA declined to $33.8 million and margin narrowed to 19.6%, but free cash flow improved to $40.9 million. Holley reiterated its full-year 2026 outlook, including net sales of $610 million to $640 million.
Holley Inc
TradingKey
Wed, Aug 5
Bioventus Q2 2026 Earnings: Pain Treatments Drive 4% Revenue Growth
Bioventus reported Q2 2026 revenue of $153.2 million, up 3.8% year over year, and GAAP diluted EPS of $0.47 versus $0.11. Pain Treatments revenue rose 11.5% and offset declines in Surgical Solutions and Restorative Therapies. A $24.6 million deferred-tax valuation allowance release drove much of the GAAP earnings increase, while adjusted EPS edged up to $0.22 and operating cash flow fell to $19.9 million. Bioventus reaffirmed its 2026 guidance while initiating a review of strategic alternatives.
Bioventus Inc
TradingKey
Wed, Aug 5
Medline Q2 2026 earnings: Sales grew while fire losses pressured profit
Medline’s Q2 2026 net sales rose 11.6% to $7.685 billion, while net income fell 58.3% to $139 million and adjusted EBITDA increased 13.4% to $1.06 billion. Existing-customer growth and implementation of 2025 customer wins supported revenue, but a $336 million loss from the Tracy distribution-center fire, higher operating expenses and tariff-related costs weighed on GAAP profit. A net IEEPA tariff refund benefit also lifted quarterly results, while Medline raised organic sales guidance and lowered its adjusted EBITDA outlook for full-year 2026.
Medline Ord Shs Class A
TradingKey
Wed, Aug 5
XPEL Q2 2026 Earnings: Record Revenue and a Wider Gross Margin
XPEL’s Q2 2026 revenue rose 14.7% year over year to a record $143.1 million, while diluted EPS increased to $0.65 from $0.59. Gross margin expanded to 44.1% from 42.9%, supporting 20.7% growth in adjusted EBITDA to $28.3 million. China-led Asia Pacific growth was the main geographic driver, while two other international regions declined. Operating cash flow reached $30.8 million, but manufacturing investments lifted investing outflows to $72.9 million. XPEL guided Q3 revenue to approximately $137 million to $139 million.
Xpel Inc
TradingKey
Wed, Aug 5
Gibraltar Q2 2026 earnings: OmniMax drives sales growth, but EPS declines
Gibraltar Industries’ Q2 2026 continuing-operations revenue rose 64.6% to $509.5 million, driven largely by OmniMax, while organic growth was 5%. GAAP diluted EPS fell 7.1% to $0.92 and adjusted EPS slipped 1.8% to $1.11 as higher interest expense and integration-related costs offset the increase in scale. Adjusted EBITDA climbed 59.7% to $88.0 million. Residential produced 83% of quarterly revenue, Agtech margins improved, and Infrastructure weakened. Gibraltar reiterated its full-year 2026 outlook while continuing OmniMax integration and synergy work.
Gibraltar Industries Inc
TradingKey
Wed, Aug 5
Griffon Fiscal Q3 2026 Earnings: Revenue Rises 7% as Margins Narrow
Griffon Corporation’s fiscal Q3 2026 revenue rose 7% to $481.4 million, driven mainly by 6% favorable price and mix, while adjusted EPS from continuing operations increased to $1.51 from $1.39. Adjusted EBITDA advanced 2% to $124.8 million, but gross and adjusted EBITDA margins narrowed as material and SG&A costs increased. The company ended June with 2.2x net leverage, projected fiscal 2026 revenue of $1.8 billion and adjusted EBITDA of $458 million, and substantially completed its shift to a pure-play building products company.
Griffon Corp
TradingKey
Wed, Aug 5
DISCO Q2 2026 Earnings: Revenue Grows as GAAP Loss Narrows
DISCO’s Q2 2026 revenue rose 13% to $43.1 million, while GAAP net loss narrowed to $8.7 million from $10.8 million and loss per share improved to $0.13 from $0.18. However, adjusted EBITDA deteriorated to a $3.4 million loss from $2.7 million as underlying operating costs remained elevated. Software revenue reached $36.8 million, and customers generating more than $100,000 over the trailing 12 months increased 10% to 354. Q3 guidance calls for $43.75 million to $45.75 million in total revenue and a smaller adjusted EBITDA loss.
CS Disco Inc
TradingKey
Wed, Aug 5
Seres Q2 2026 Earnings: A $25 Million VOWST Gain Drives Quarterly Profit
Seres Therapeutics reported Q2 2026 grant revenue of $736,000 and diluted EPS of $0.47, compared with no revenue and a $2.27 loss per share a year earlier. Net income reached $4.6 million, but the result was driven by a $25 million gain tied to the VOWST milestone buyout while operations still lost $21.3 million. The company ended June with $15.6 million in cash and expects funding to last through Q1 2027. SER-155 also posted an 80% day-15 response rate in a 15-patient irEC study.
Seres Therapeutics Inc
TradingKey
Wed, Aug 5
Orion Fiscal Q1 2027 Earnings: Margin Expansion Restores Profitability
Orion Energy Systems’ fiscal Q1 2027 revenue rose 32% to $25.7 million, while diluted EPS improved to $0.47 from a $0.37 loss a year earlier. Gross margin expanded 450 basis points to 34.6%, helping the company deliver $2.0 million of net income and a seventh consecutive quarter of positive adjusted EBITDA. LED lighting and EV charging led growth, operating cash flow turned positive, and Orion reiterated fiscal 2027 revenue guidance of $95 million to $97 million with positive adjusted EBITDA. The main watchpoints are large-project timing, EV funding uncertainty, tariffs, and ERP execution.
Orion Energy Systems Inc
TradingKey
Wed, Aug 5
1
...
34
35
36
36
/
47
37
38
...
47
Featured Tools
Markets
Economic Calendar
SmartPicks
Weekly Report
Popular Instruments
Name
Price
Chg%
US30
US30
--
--
NAS100
NAS100
--
--
SPX500
US500
--
--
Top News
Oracle Stock Forecast: $630 Billion AI Order Backlog Awaits Revaluation, Can the Stock Continue to Recover?
Micron vs. SK Hynix: As HBM Demand Continues to Surge, Which Memory Stock Deserves More Attention?
New CEO Ternus Launches iPhone 18 Pro on September 9 — Can Apple Reverse Q3 China Miss Before Jackson Hole?
Micron Stock Forecast: Can AI Memory Demand Push MU Above $1,000?
Western Digital Shares Plunge 50%: Is It the Best Time to Buy?
Market Movers
BNB (BNBUSD) Suddenly Goes down 1.02% on Aug 16: What You Need to Watch
11 hours ago
BNBUSD
--
Fortinet Inc Stock (FTNT) Closed Down by 3.41% on Aug 14: A Full Analysis
Fri, Aug 14
FTNT
--
Silicon Motion Technology Corp Stock (SIMO) Closed Up by 7.70% on Aug 14: What Signal Does It Send?
Fri, Aug 14
SIMO
--
Palo Alto Networks Inc Stock (PANW) Closed Down by 3.33% on Aug 14: A Full Analysis
Fri, Aug 14
PANW
--
Lumentum Holdings Inc Stock (LITE) Closed Up by 5.18% on Aug 14: A Full Analysis
Fri, Aug 14
LITE
--